What is the significance of vascular hydrogen sulphide (H 2S)?

British Journal of Pharmacology

Volumn 149, Issue 6, 2006, Pages 609-610

  O'Sullivan, S E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Blood pressure; Hydrogen sulphide; Nitric oxide; Nitrosothiol; Vasculature; Vasoconstriction; Vasorelaxation

Indexed keywords

HYDROGEN SULFIDE; NITRIC OXIDE; NITRIC OXIDE DONOR;

BIOSYNTHESIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CONCENTRATION (PARAMETERS); DRUG EFFECT; DRUG INFUSION; HUMAN; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SEPSIS; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD VESSELS; HUMANS; HYDROGEN SULFIDE; VASOCONSTRICTION;

EID: 33750994630     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706907     Document Type: Review

References (12)

1. Ali MJ, Ping CY, Mok YP, Ling L, Whiteman M, Bhatia M et al. (2006). Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol 149: 625-634 (this issue).
2. Allen BW, Piantadosi CA (2006). How do red cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm. Am J Physiol Heart Circ Physiol 291: H1507-H1512.
3. Anuar F, Whiteman M, Siau JL, Kwong SE, Bhatia M, Moore PK (2006). Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat. Br J Pharmacol 147: 966-974.
4. Cheng Y, Ndisang JF, Tang G, Cao K, Wang R (2004). Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287: H2316-H2323.
5. Chvanov M, Gerasimenko OV, Petersen OH, Tepikin AV (2006). Calcium-dependent release of NO from intracellular S-nitrosothiols. EMBO J 25: 3024-3032.
6. Dombkowski RA, Russell MJ, Schulman AA, Doellman MM, Olson KR (2005). Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol 288: R243-R252.
7. Jiang HL,Wu HC, Li ZL, Geng B, Tang CS (2005). Changes of the new gaseous transmitter H2S in patients with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao 25: 951-954.
8. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ et al. (2005). Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 19: 1196-1198.
9. Mok YY, Atan MS, Yoke Ping C, Zhong Jing W, Bhatia M, Moochhala S et al. (2004). Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol 143: 881-889.
10. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR et al. (2006). Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41: 106-119.
11. Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M et al. (2006). Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 343: 303-310.
12. Zhao W, Zhang J, Lu Y, Wang R (2001). The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 20: 6008-6016.